Stimulating Amyloid Clearance in Cerebral Amyloid Angiopathy

PHASE2Enrolling by invitationINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 27, 2025

Primary Completion Date

September 27, 2027

Study Completion Date

September 27, 2027

Conditions

Cerebral Amyloid Angiopathy

Interventions

DRUG

XYWAV

Daily before bedtime for 3 months

DEVICE

gammaCore Sapphire

Twice daily for 3 months

Trial Locations (1)

Leiden University Medical Center (LUMC), Leiden

All Listed Sponsors

collaborator

The Dutch Brain Foundation

OTHER

lead

Leiden University Medical Center

OTHER